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Abstract
Background: Obesity has become one of the greatest health risks in the U.S. Obesity is one of the largest
causes of mortality in the country leading to the development of cardiovascular disease, liver disease, and
endocrine disorders, to name a few. For decades, the gold standard in predicting a person’s likelihood of
developing complications secondary to obesity has been their body mass index (BMI). While BMI succeeds
in identifying many who are at risk for developing the complications listed above, there are some individuals
who may not receive the proper treatment and preventative measures because they have a normal BMI and
excess abdominal adipose tissue. This has lead researchers to investigate whether waist-to-hip ratio or BMI is a
better predictor of total mortality in people who have a visceral fat distribution.
Methods: An exhaustive search of the following databases was performed using MEDLINE (Ovid), Google
Scholar, and Web of Science using the key terms: normal weight central obesity, healthy, abdominal obesity,
and mortality. Articles which evaluated only human participants and written in the English language were
reviewed for quality using the GRADE criteria.
Results: Searches of published research returned a total of 104 articles, of which three matched the search
inclusion criteria and were read in their entirety. Two of these articles were evaluated using the GRADE
guidelines. One study was a stratified multistage probability design using NHANES III data while the other
study was a prospective cohort study using data from the Dutch EPIC-MORGEN study.
Conclusion: Studies suggest that while BMI serves as a useful screening tool, it does not sufficiently identify
all individuals who may be at risk for developing complications and mortality secondary to obesity. Waist-to-
hip ratio may more accurately identify individuals who are at a higher risk of developing obesity related health
complications. Some studies have even shown an inverse relationship between BMI and mortality.
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Abstract  
Background: Obesity has become one of the greatest health risks in the U.S. Obesity is one of 
the largest causes of mortality in the country leading to the development of cardiovascular 
disease, liver disease, and endocrine disorders, to name a few. For decades, the gold standard in 
predicting a person’s likelihood of developing complications secondary to obesity has been their 
body mass index (BMI). While BMI succeeds in identifying many who are at risk for developing 
the complications listed above, there are some individuals who may not receive the proper 
treatment and preventative measures because they have a normal BMI and excess abdominal 
adipose tissue. This has lead researchers to investigate whether waist-to-hip ratio or BMI is a 
better predictor of total mortality in people who have a visceral fat distribution. 
Methods:  An exhaustive search of the following databases was performed using MEDLINE 
(Ovid), Google Scholar, and Web of Science using the key terms: normal weight central obesity, 
healthy, abdominal obesity, and mortality. Articles which evaluated only human participants and 
written in the English language were reviewed for quality using the GRADE criteria. 
Results:  Searches of published research returned a total of 104 articles, of which three matched 
the search inclusion criteria and were read in their entirety. Two of these articles were evaluated 
using the GRADE guidelines. One study was a stratified multistage probability design using 
NHANES III data while the other study was a prospective cohort study using data from the 
Dutch EPIC-MORGEN study. 
Conclusion:  Studies suggest that while BMI serves as a useful screening tool, it does not 
sufficiently identify all individuals who may be at risk for developing complications and 
mortality secondary to obesity. Waist-to-hip ratio may more accurately identify individuals who 
are at a higher risk of developing obesity related health complications. Some studies have even 
shown an inverse relationship between BMI and mortality. 
Keywords:  BMI, Body mass index, waist-to-hip ratio, WHR, central obesity, normal weight, 
normal BMI, visceral fat, abdominal obesity, total mortality, metabolically healthy 
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Waist-To-Hip Ratio vs. Body Mass Index as a Predictor of Total Mortality for People with 
Normal Weight and Central Obesity 
BACKGROUND 
 According to the Centers for Disease Control and Prevention, obesity accounts for about 
10 percent of the national medical budget costing the country about $150 billion each year. It is 
estimated that 33 percent of adults and 17 percent of children are obese.1 These numbers would 
undoubtedly be much larger if they included individuals with abdominal obesity, but a normal 
body mass index (BMI). Obesity rates in the U.S. have increased drastically over the last several 
decades reaching epidemic levels. The reasons for this phenomenon are multifaceted and cross 
cultural and socioeconomic barriers. Some of the reasons for the rise in obesity include changes 
to the average American’s diet with the prevalence of processed foods and fast food eating 
establishments, reduced activity levels, and technological advances that make physical activity 
less appealing.  
Regardless of the reasons behind an individual’s obesity, it is clear that improvements 
need to be made concerning the identification and treatment of individuals at risk for the 
avoidable complications and deaths which result from being obese. For decades the medical 
profession has used BMI as a screening tool to identify who is at risk for developing 
complications secondary to long-term obesity. BMI is obtained by taking a person’s weight in 
kilograms and dividing it by their height in meters squared. For example, a person weighing 68 
kg with a height of 1.65 m would have a BMI of 24.98.2  The individual in the example above 
would be categorized as being a normal or healthy weight (see Table 1). The use of BMI is so 
prevalent in the medical field because it is an inexpensive and easy screening tool that can be 
done at any visit. While BMI is an estimate that does not directly measure a person’s actual body 
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fat, the CDC states that it has moderate correlation to other tools which more directly measure 
adipose tissue.2   
There has been some speculation within the medical community that not all fat deposits 
are created equal. Screening for total mortality using BMI alone fails to capture a portion of the 
population who may have a normal BMI but are at risk for developing complications of obesity 
because of their visceral fat deposits. The American Heart Association along with the American 
College of Cardiology and The Obesity Society recommend using BMI and waist circumference 
(WC) to screen for patients who need to lose weight (see Figure 1). They recommend identifying 
patients with a BMI over 25.0 kg/m2 (overweight) who may be at risk for cardiovascular disease, 
and patients with a BMI over 30.0 kg/m2 (obese) who may be at risk for mortality. In addition to 
calculating BMI, these guidelines recommend measuring WC for individuals who are overweight 
or obese according to BMI. These guidelines make the assumption that an individual with a 
normal BMI (<25 kg/m2) is not at risk for any type of obesity-related sequelae. Practitioners 
following these guidelines may fail to adequately screen patients who may be at risk for 
developing cardiovascular disease or other complications of obesity because their BMI 
measurements do not take into consideration the distribution of adipose tissue concentrated to the 
abdomen. 
The World Health Organization defines abdominal obesity as having a waist-to-hip ratio 
(WHR) ≥0.90 for men and a WHR ≥ 0.85 for women.3 A large cohort study by Berentzen et al4 
looked at the changes in WC compared to changes in BMI and found that changes in BMI were 
inversely associated with mortality while changes in WC were positively associated with 
mortality. This study showed that the hazard ratio for the change in BMI was 0.91 per kg/m2 
while the hazard ratio for the change in WC was 1.09 per 5 cm for the combined sexes. When 
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combining the two measurements the hazard ratio increased to 1.15 for an increase in WC with a 
concurrent drop in BMI. Conversely the hazard ratio dropped to 1.02 in participants with an 
increase in both WC and BMI.4   
To many, these findings are counterintuitive and appear to contradict what the general 
population has been led to believe concerning BMI and its usefulness as a screening tool for 
morbidity and mortality. Knowing this, it is important that early and accurate screening be used 
to help patients avoid unnecessary complications of their obesity. The importance of this issue 
has led many researchers to ask whether WHR or BMI is a better predictor of total mortality for 
people with normal weight and central obesity.  
METHODS 
 An exhaustive search of available literature was performed using MEDLINE (Ovid), 
Google Scholar, and Web of Science. The searches were carried out using the following 
keywords: normal weight central obesity, healthy, abdominal obesity, and mortality. Eligibility 
criteria included research conducted on individuals with a normal BMI (<25.0) who have central 
obesity in comparison with individuals who have a normal BMI with no central obesity and 
individuals with an increased BMI (>25) with no central obesity.  
The articles which met the inclusion criteria that were completed using humans or human 
tissue and written in the English language comprised the pool of available studies. The chosen 
studies were then evaluated for quality using the Grading of Recommendations, Assessment, 
Development and Evaluation (GRADE) criteria (see Table 1).5  
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RESULTS 
 The search resulted in a total of 104 articles which were reviewed for appropriateness. Of 
the above articles, three were included for consideration and read in their entirety. Upon 
application of the inclusion criteria stated previously, two articles remained.6,7 
Sahakyan et al 
The Sahakyan et al study6 is a stratified multistage probability design study of the Third 
National Health and Nutrition Examination Survey (NHANES III) which included 15 184 adults 
aged 18 to 90 years who had available WHRs, a BMI greater than 18.5 kg/m2, and no history of 
cancer other than skin cancer. This study evaluated the hazard ratios of individuals with various 
BMIs and WHRs using Cox proportional hazard models. Study participants were compared to a 
model of various BMIs and WHRs combinations to establish appropriate total mortality hazard 
ratios. A BMI of 22.0 kg/m2 represented an individual with a normal BMI, a BMI of 27.5 kg/m2 
represented a classification of overweight, and a BMI of 33 kg/m2 indicated that someone was 
obese. For men, a WHR of 0.89 indicated they were not centrally obese while a WHR of 1.0 
indicated central obesity. For women, a WHR of 0.80 indicated non-centrally obese and a WHR 
0.92 was the model for central obesity (see Tables 3 & 4).6 
 This study had a mean follow-up period of 14.3 years, during which time there were 3222 
deaths, 1404 from cardiovascular disease. In a comparison of various mixtures of BMI and body 
fat distribution, it was found that men with a normal BMI and central obesity (Row 2 Column 2 
in Table 3) have a higher total risk of mortality than any other combination of BMI and adipose 
tissue distribution. The study found that men with a BMI less than 25 kg/m2 who had visceral fat 
deposits had an 87 percent higher mortality risk than their peers with similar BMIs but no 
abdominal adiposity. Further comparison of the figures seen on Table 3 show that a centrally-
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obese male with a normal BMI has twice the risk of mortality than a male who is overweight 
according to BMI but is not centrally obese. For women with a normal BMI and central obesity, 
total mortality risk was 48 percent higher than a woman with a similar BMI but no excessive 
visceral fat deposits (see Table 4).6 
 Expected mortality rates during a 10 year period are markedly higher than those observed 
over a 5 year course. “The effect of central obesity on 5- and 10-year survival across all age 
groups is pronounced. The rank-ordering pattern of expected survival, both within age groups 
and overall, consistently favors men with less central obesity. The same general pattern is seen in 
women.” The authors note that the mortality risks associated with an individual having notable 
visceral fat deposits for a prolonged period of time additionally call into question the current 
guidelines of screening for individuals who should lose weight (see Figure 1).6 
van der A et al 
This prospective cohort study7 followed 22 654 Dutch individuals aged 20-59 for an 
average of 13.4 years and examined the mortality risk of individuals classified as metabolically 
healthy abdominal obese (MHAO) in comparison to the reference group of individuals who were 
metabolically healthy non-abdominal obese (MHNAO). The study also compared the risks of 
MHAO individuals to those who were metabolically unhealthy non-abdominal obese (MUNAO) 
and metabolically unhealthy abdominal obese (MUAO) individuals. A study participant’s 
classification of metabolic health were based on the presence the following metabolic risk 
factors: waist circumference (≥102 cm in men, ≥88 cm in women); hypertension (SBP ≥130 
and/or DBP 85 mmHg and/or use of antihypertensive medication); dyslipidemia was defined as 
total cholesterol ≥6.5 mmol L-1, and/or HDL-C <1.03 mmol L-1 (men) or <1.29 mmol L-1 
(women), and/or use of cholesterol-lowering medication; and hyperglycemia was defined as 
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nonfasting plasma glucose ≥7.8 mmol L-1 and/or self-reported diabetes. Using the MHNAO 
group as reference, the study designers calculated hazard ratios through Cox proportional 
regression analysis.7 
 The study found that nearly 23 percent of the study participants were abdominally obese 
with 20 percent of those individuals being metabolically healthy. During the study’s 13.4 year 
follow up, 838 individuals passed away. When compared to MHNAO, the total mortality hazard 
ratio of MHAO participants was 1.43 (95% CI: 1.00-2.04). The study also found that the total 
mortality risk for MHAO individuals was of the same magnitude of MUNAO individuals 
(MUNAO to MHNAO HR 1.31).7  The comparison of MUAO to MHAO reveals a hazard ratio 
of 1.12 showing that, while MUAO individuals have a higher total mortality risk, the difference 
is not very significant. As seen in the study cited above, the “data suggests that it may take at 
least a decade before metabolic changes arise as a result of obesity” showing that men who had 
abdominal obesity for longer than 10 years had a twofold increase in the occurrence of elevated 
triglycerides and metabolic syndrome.7 
 Analysis of the four phenotypes listed earlier showed that, when defined by waist 
circumference, abdominally obese adults were less likely to be metabolically healthy when 
compared to BMI-defined obesity measures. Comparison of the MHAO and MUAO groups 
revealed that while the MHAO group was less obese, there were no significant differences in the 
presence of preexisting myocardial infarction, stroke, cancer, past surgeries, or persistent back 
problems. Both groups showed an increased risk in total mortality when compared to the 
MHNAO individuals. The researchers suggest that the MHAO group may just be a transitional 
stage on the way to becoming metabolically unhealthy.7   
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DISCUSSION 
 Obesity has reached epidemic status here in the U.S. and abroad. When solely 
categorized by BMI (see Table 1), the problem appears massive and results in unnecessary drains 
on the economy, productivity, and healthcare resources.1 If the negative externalities of the 
obesity problem were to include complications experienced by individuals of normal weight with 
central obesity as measured by WHR according to the World Health Organization3 (≥0.90 for 
men and ≥ 0.85 for women), the figures would be staggering. Whether or not the official 
measure of obesity should be amended to include those who are of normal weight with central 
obesity, it is clear that more needs to be done to identify those who are at an elevated risk of 
morbidity and mortality secondary to obesity.  
 Current guidelines for identification of patients who are at an elevated risk of morbidity 
and mortality and need to lose weight only capture a portion of the total population at risk (see 
Figure 1). The Berentzen et al study4 postulates that peripheral subcutaneous fat deposits which 
are more likely to lead to a person being categorized as overweight or obese according to BMI 
may actually be beneficial as seen in the inverse relationship noted between BMI and mortality. 
Individuals with peripheral subcutaneous fat distribution, specifically around the hips and thighs, 
appear to be less likely to suffer from metabolic syndrome and other inflammatory processes 
which are more strongly correlated to visceral fat deposits.  
 Both studies used Cox hazard statistical analysis to make the data comparable across 
varying body types and measures of adiposity. And while the above studies had serious 
limitations (see Table 2), these were not significant enough to detract from the combined 
findings which more strongly correlate cardiovascular and total mortality to abdominal obesity 
than to obesity as measured by BMI alone. The cursory review of results returned in the initial 
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search of published literature appears to show a growing consensus that visceral adiposity is a 
better predictor of an individual’s total mortality. The articles chosen for this review focused on 
persons with a normal BMI who have abdominal obesity and the research shows that individuals 
with this phenotype are at an increased risk when compared to those who do not have abdominal 
obesity, regardless of their BMI.  
The Sahakyan et al study6 was found to have several strengths including length of follow 
up. The long follow up revealed that there is an increase in mortality when 5- and 10-year 
expected mortality rates are compared. In addition to length of follow up the study’s other main 
strength was the large sample size which included a population that is representative of the U.S. 
population in regards to race, culture, age, and socioeconomic status.  
 This study6 also contained several limitations. Among those limitations were the self-
reporting of comorbidities which is prone to error; however, underreporting of comorbidities is 
likely to lessen the correlation between WHR and mortality. The NHANES III study also 
measured WC differently than the method recommended by the WHO3 which may make 
comparisons to other studies difficult or impossible. And finally, the study used WHR ratio as a 
measure of visceral obesity. While this method is more accurate than BMI at identifying 
abdominal adiposity, use of imaging such as computed tomography would more accurately 
differentiate between visceral and subcutaneous fat. 
The van der A et al study7 also had several strengths. The study’s 13.4 year average 
follow up revealed similar trends of worsening outcomes the longer an individual is centrally 
obese. Comparable to the Sahakyan et al study, this study’s large sample size proved to be a 
valuable strength. Researchers had access to wide-ranging information on participants’ lifestyle, 
diet, activity levels, medical history, etc. While a large sample size increases the study’s validity 
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and applicability, the study participants were all from the Dutch population and the relatively 
narrow age range of adults between 20 and 59 years of age also limits how the data maybe be put 
to practical use. The study may also have misclassified some participants with hyperglycemia 
and hyperlipidemia as a result of non-fasting blood levels being collected rather than fasting 
blood levels. Metabolically unhealthy individuals may been underreported as a result of not 
measuring triglyceride and insulin levels as well as any inflammatory markers. Finally, this study 
also measured WC instead of computed tomography to estimate visceral obesity. While many 
studies have found that the correlation between the two is strongly positive, WC fails to 
accurately differentiate between what the researchers call “metabolically active visceral fat and 
the less metabolically active subcutaneous fat.”7 
 More research needs to be done to address the limitations of these studies and to discover 
the physiologic mechanisms shown in studies where BMI is inversely related to mortality, as 
well as the precise mechanisms that make abdominal obesity so damaging. While some have 
speculated that having central obesity for longer than 10 years triggers the activation of multiple 
inflammatory processes which then results in the development of metabolic syndrome and 
cardiovascular disease, not enough is known about these metabolic pathways to confirm this 
hypothesis. 
CONCLUSION 
 Studies have shown that screening all patients with WHRs appears to be a better and 
more precise way of identifying risk of total mortality when compared to calculating BMI. 
Current guidelines do not adequately identify those who have an elevated risk of mortality 
secondary to obesity, and further studies are recommended to address the limitations mentioned 
above and to establish the best way to screen at risk individuals. Given that it is not feasible or 
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safe for every person to undergo repeated computed tomography scans to screen for the presence 
of visceral fat deposits, it is reasonable to continue to use WHRs as an easy and reliable means of 
assessing a person’s abdominal obesity.  
 In light of the results documented in this review, practitioners may want to give serious 
consideration to utilizing WHR and BMI in conjunction to screen all patients regardless of BMI 
in order to more precisely identify those who have an elevated risk of total mortality secondary 
to obesity. Many electronic medical record programs utilized in clinical practice automatically 
calculate a patient’s BMI based on height and weight measurements collected at each visit. In 
addition to this calculation, patients should have their WHR’s calculated at least annually. These 
additional measurements are so easily and quickly obtained that it would be feasible to collect 
them at each office visit. While some may see this as an unnecessary step, the information 
gleaned from this simple approach may slow the development of many unnecessary health 
complications and deaths for patients who may not know they are at risk. Using BMI and WHR 
to screen and educate patients about their health risks will result in significantly fewer dollars 
spent on the treatment of obesity-related diseases. In addition to the cost savings, patients will be 
able to increase their lifespans by decreasing their waistbands.  
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Tables 
 
 
Table 1. BMI Weight Status Categories 
BMI Weight Status 
Below 18.5 kg/m2 Underweight 
18.5 - 24.9 kg/m2 Normal or Healthy Weight 
25.0 - 29.9 kg/m2 Overweight 
30.0 kg/m2 and Above Obese 
 
 
 
Table 2: Quality Assessment of Reviewed Articles 
Study Design 
Downgrade Criteria 
Upgrade 
Criteria 
Quality 
Limitations Indirectness Inconsistency Imprecision 
Publication 
bias 
Sahakyan et 
al6 
Stratified 
multistage 
probability 
design 
Not serious 
a,b 
Not Serious Not Serious Not Serious Unlikely None Low 
Van Der A 
et al7 
Cohort Serious a,c,d Not Serious Not Serious Not Serious Unlikely None Very 
low 
a WC instead of CT for abdominal obesity 
b Self-reporting of comorbidities 
c Limited geography and ages for sample 
d Collection of non-fasting blood samples 
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Table 3. Hazard Ratios for Total Mortality for Men 
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Table 4. Hazard Ratios for Total Mortality for Women 
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Figure I. AHA/ACC/TOS Screening Guidelines 
(http://circ.ahajournals.org/content/129/25_suppl_2/S102/T4.expansion.html) 
 
 
 
 
 
